High performance liquid chromatography coupled with tandem mass spectrometry was developed and validated as a method for the analysis of fluorinated histone deacetylase inhibitors (F-HDACi), and then employed to study their metabolism in biosystems. Four HDACi analogs labeled with the positron emission nuclide 18 F constitute a group of potential positron emission tomography imaging agents, which were developed by the Institute of Nuclear Energy Research (INER) and coded as INER-1577 #1, #2, #3, and #4 during animal studies for the diagnosis of dementia. The performance of the method was found to be suitable for the determination of analog #3, and it was employed to determine the structures and fragmentation mechanisms of all four analogs and to study the biotransformations of analogs #3 and #4. The results indicated that the method used for the determination of analog #3 was suitable for determining the abundance of the analogs in chemical and biochemical tests with high precision, accuracy, reproducibility, and recovery. Weaknesses in the chemical bonding of the analogs were found to involve the fluoro, dimethylamino, and benzamide groups in a fragmentation mechanism deduced via tandem mass spectrometry. The metabolites of analogs #3 and #4 in rat liver microsomes and rat plasma were also identified to clarify their characteristic behaviors in biosystems. The major product of analogs #3 in liver mi- crosomes was produced by hydroxylation of the benzylic carbon atom, but in rat plasma the metabolites of analog #3 were produced by hydrolysis of the benzamide group to give a diaminobiphenyl compound with the simultaneous replacement of a fluorine atom by a hydroxyl group. The metabolites of analog #4 in liver microsomes were produced by hydroxylation of the benzylic carbon atom and hydrolysis of the benzamide bond. The results of the studies characterized the chemical and biochemical behaviors of the series F-HADCi analogs.
Introduction
Progressive central neurodegenerative diseases and symptoms of cognitive loss affect more than 20% of people with ages of greater than 65 years worldwide, which lead to partial cognitive impairment or various levels of dementia [1] . Because of the high prevalence of these conditions and the resulting heavy burden on patients' families and serious social problems, the development of an early stage diagnostic method is critical for mitigating patients' conditions, in preference to characterization at a late stage. Molecular imaging techniques, including the application of radiotracers in positron emission tomography (PET) and single-photon emission computed tomography [2] [3] [4] , which provide clear, unambiguous, and detailed diagnostic images of the central nervous system (CNS), are the most powerful tools for assessing the phases of CNS diseases. The development of highly specific and sensitive imaging markers for various CNS diseases is an essential component of imaging diagnosis [4] .
Histone deacetylase (HDAC) and histone acetyl transferase (HAT), which are key enzymes that govern the binding of acetyl groups to histone and adjust gene expression, have been shown to be involved in numerous types of cancer and neurodegenerative disorder [5] . A few studies indicated that HDAC inhibitors could treat cancer [6] [7] [8] and also improve memory [8] , which was explained in terms of epigenetics theories as follows [9] [10] . Gene expression and cell proliferation are regulated by the remodeling of chromatin, whereby the DNA complex is wrapped around histone or unwrapped, while histone is acetylated by HATs or acetyl groups are removed by HDACs. This indicated that memory ability is positively related to the degree of acetylation of lysine, which is the terminal amino acid of histone, to create acetyl-lysine. This was concluded from the inhibition of the activity of HDACs with HDAC inhibitors (HDACis), which led to an increase in acetylation. HDACis were suggested to act as neuroprotectors by enhancing synaptic plasticity and cognition ability in cases of neurode-W.-H. Chen et al. Int . J. Analytical Mass Spectrometry and Chromatography generation and cognitive impairment, such as Alzheimer's disease (AD) [11] .
The inhibition of the activity of HDACs is more efficient than the enhancement of the activity of HATs in regulating the status of chromatin and improving learning ability [11] [12] . A few drug candidates in animal models of AD were found to reverse learning and memory deficits, such as suberoylanilide hydroxamic acid (SAHA) [13] , tubacin [14] , and tubastatin [15] . Owing to the specific and critical role of HDACis in AD patients, the development of PET imaging agents that utilize an HDACi mechanism to visualize pathogenesis in the brains of patients with mild cognitive impairment or AD is particularly interesting [16] .
For example, 6-([ F-FAHA, which is a radio-fluoro labeled SAHA analog, has been used as an imaging agent [17] . On the other hand, containing benzamide group compounds as HDAC inhibitors, such as mocetinostat, MGCD0103 and entinostat, MS-275 showed the potentials to therapy for cancer were under clinical trials [18] .
A series of four target analog HDAC inhibitors containing benzamide groups and fluoro substituents were designed, and their synthesis processes were devel- 
Materials and Methods

Materials and Reagents
Analytical-grade chemicals for LC-MS were used as received without further pu- 
Analytical Equipment
The purities of the synthesized INER-1577s, and their molecular fragmentation mechanisms and biotransformation behavior in rat liver microsomes and rat plasma, were analyzed using an HPLC system (Agilent 1100/1200 series, Palo
Alto, CA, USA) with an online degasser, binary pump, autosampler, and diode array detector (DAD). Data were acquired and processed using Agilent ChemStation 10.02 software. The HPLC system was coupled with a tandem mass spectrometer (4000QTRAP, AB Sciex, Concord, ON, Canada, using Analyst 1.6.2 software via a splitter (10:1). The mass spectrometer was equipped with an electrospray ionization source, and a triple quadrupole linear ion trap mass detector and was operated in positive-ion detection mode. 
Validation of HPLC-MS/MS Analytical Method for Determination of INER-1577 #3
The HPLC-MS/MS analytical method was set up and validated for the determi- 
Procedures Used for Biotransformation Studies of INER-1577s
The studied INER-1577 standards were separately dissolved in DMSO (1
) and mixed with bio-reaction systems (rat liver microsomes and rat plasma) for several time intervals (up to 4 h) before the bio-reaction was quenched by the addition of methanol (1:1 volume), followed by mixing and centrifugation (6000 rpm at 4˚C for 10 min). The resulting supernatant was filtered through a 0.22-μm PVDF disk filter and analyzed via HPLC-MS/MS. Details of the conditions used for incubation of the tested compounds with rat liver microsomes and rat plasma are provided in [22] , and the directions followed are given in [23] (microsomes) and [24] (plasma).
Results and Discussion
Development and Validation of LC-MS Analytical Method for Determination of INER-1577 #3
To Table 1 . The chromatogram of INER-1577 #3 is shown in Figure   2 (a). and the retention time (t R , min), theoretical plate number (N), resolution factor, selectivity factor and tailing factor were 11.8 ± 0.15, 18,400, 1.75, 1.06, and 1.15, respectively. The chromatographic purity was 99.55% based on the ratio of its peak area to those of all component peaks (DAD detection, except for the system and background peaks). The dynamic range was 0.5 -100 mg·L −1 with 
Application to Determine the Purities of INER-1577 Analogs
Before the characteristics of a chemical are studied, it is important to check its quality. The analytical method used for INER-1577 #3 was also employed to determine the purities of #1, #2, and #4. The chromatograms of the analogs are shown in Figures 2(b)-(d) . The purity of INER-1577 #1 was 40.7% with a retention time (t R ) 7.6 min (m/z = 365), and the major impurity in the material was its non-fluorinated precursor (m/z = 347), of which the content was 52.4% (t R = 12.55 min). The efficiency of the fluorination reaction used to prepare INER-1577 #1 was thus unsatisfactory. For INER-1577 #2 analogue, the chromatographic purity was 97.0% (m/z = 364) and t R was 10.1 min, accompanied by six insignificant impurities. For INER-1577 #4, t R was 12.9 min and the chromatographic purity was 95.5% (m/z = 482) with seven detectable minor impurities.
Fragmentation Mechanisms of INER-1577s
To determine the chemical bonding characters and compile a basic data bank of the mass spectra of the HDACi analogs, which is helpful for the identification of derivatives and to understand structural weaknesses, their fragmentation mechanisms were studied using tandem mass spectra. 
Identification of Metabolites of INER-1577s in Biosystems
Because the structures of the four INER-1577 analogs are similar, the types of chemical bond in INER-1577 #3 and #4 could represent those in #1 and #2. The biochemical behavior of the compounds was therefore studied by incubating #3 and #4 in rat liver microsomes and/or rat plasma. A liver microsome protocol is often used to study the metabolic pathways of xenobiotics and the catalysis of phase I and II reactions [23] . In the study, no endogenic substances such as sulfate, glucose, amines, or amino acids were supplied. Those are required by phase II reactions, and conjugated products could therefore not be detected in the system. In general, phase II conjugated metabolites are non-bioactive. On the other hand, the tested materials are administered via intravenous injection (iv) and are Int. J. Analytical Mass Spectrometry and Chromatography delivered to the organs and CNS by the body's circulatory system, and might be metabolized in the blood before they arrive at the CNS to bind with the specified sites, as was originally intended. Therefore, a study of its metabolic pathway and metabolization rate in plasma is pivotal for the appropriate use of a drug [24] .
Firstly, INER-1577 #3 was biotransformed in a rat liver microsomes/NADPH coenzyme system for a specified period, and then its abundance was monitored via its chromatographic peak area (DAD 250 nm) over a period time after the incubated solutions were pretreated. The chromatographic separation of INER-1577 #3 and its metabolites in liver microsomes is shown in Figure 4 The mechanisms of the metabolism of INER-1577 #3 in liver microsomes and plasma, and #4 in liver microsomes are outlined in Figure 6 (a) and Figure 6 (b), respectively. The biotransformation of INER-1577 #3 by liver microsomes was diverse including demethylation or hydroxylation of the dimethylamino group, methylene hydroxylation of the benzylamino and fluoroethylamino groups, the replacement of the fluorine atom by a hydroxyl group, and carboxylation of the fluorine-bearing carbon atom. On the other hand, for INER-1577 #3 in plasma only hydrolysis of the benzamide group and, at the same time, the substitution of a hydroxyl group for the fluorine atom whereas observed. Fluorine atom might be removed from INER-1577 #3 after it had been biotransformed, and its partial metabolites were thus untraceable by PET graph. The metabolism of INER-1577 #4 by liver microsomes proceeded via two routes: hydrolysis of the benzamide group to give a pair of products, namely, benzoic acid and diaminopyridylmoieties, and hydroxylation of the methylene carbon of the benzyl-amino group. The fluorine atom on the phenyl group of INER-1577 #4 was not removed from the ligand, which thus remained radio-traceable. Therefore, the bio-stability of F-C bonds is less for alkyl-F bonds than for phenyl-F bonds. Because the indolino group of INER-1577 #4 restricted reactions at the tertiary amine group, its biotransformations were simpler than those of INER-1577 #3. Moreover, the potential metabolites of INER-1577 #3 and #4 produced in the liver and plasma were more hydrophilic and it was thus difficult for them to cross the blood-brain barrier (BBB) into the CNS for imaging. Because HDACs are zinc-centered metallo-enzymes [25] , and the benzamide groups of the INER-1577 analogs compete with amino acids for coordination with zinc atoms [26] , the function of the analogs is terminated after hydrolysis of the benzamide groups in the liver or blood. Although the researches indicated that benzamide derivatives showed anticancer activities under phase II clinical trials based on HDAC inhibition, there is no information available on its microsomal stability and metabolism for mocetinostat (MGCD0103) and no metabolites could be detected after incubation of MS-275 in human liver microsomes for entinostat (MS-275) [27] . Int. J. Analytical Mass Spectrometry and Chromatography 
Conclusion
According to the study results, the reactive chemical bonds and biochemical characteristics of the INER-1577 analogs were well defined. It is suggested that PET imaging should be performed immediately after the ligand reaches distribution equilibrium in the CNS and end within 1 h after i.v. administration. The ligands are inactivated after biohydrolysis of the benzamide groups of INER-1577 #3 and #4 to give smaller molecules, and hydroxylation to give more hydrophilic metabolites could promote the excretion of the ligand via urine. Although the Int. J. Analytical Mass Spectrometry and Chromatography radioactive nuclide 18 F is removed from the INER-1577 #3 ligand after metabolism and is transported around the body, its half life is short (109 min, with 18 O as its daughter nuclide) and it is easily excreted via urine. Therefore, the bio-safety of the INER-1577s has been confirmed.
